BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26223576)

  • 1. Role of microRNAs Located on Chromosome Arm 10q in Malignant Gliomas.
    Wolter M; Werner T; Malzkorn B; Reifenberger G
    Brain Pathol; 2016 May; 26(3):344-58. PubMed ID: 26223576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy.
    Krell A; Wolter M; Stojcheva N; Hertler C; Liesenberg F; Zapatka M; Weller M; Malzkorn B; Reifenberger G
    Neuropathol Appl Neurobiol; 2019 Aug; 45(5):441-458. PubMed ID: 30548945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-146b-5p inhibits glioma migration and invasion by targeting MMP16.
    Li Y; Wang Y; Yu L; Sun C; Cheng D; Yu S; Wang Q; Yan Y; Kang C; Jin S; An T; Shi C; Xu J; Wei C; Liu J; Sun J; Wen Y; Zhao S; Kong Y
    Cancer Lett; 2013 Oct; 339(2):260-9. PubMed ID: 23796692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
    Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
    Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas.
    Wang C; Chen Q; Li S; Li S; Zhao Z; Gao H; Wang X; Li B; Zhang W; Yuan Y; Ming L; He H; Tao B; Zhong J
    Oncotarget; 2017 Feb; 8(6):10287-10297. PubMed ID: 28055966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas.
    Qian J; Li R; Wang YY; Shi Y; Luan WK; Tao T; Zhang JX; Xu YC; You YP
    Mol Cell Biochem; 2015 May; 403(1-2):33-41. PubMed ID: 25648114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of the miR-126 gene associated with glioma progression.
    Cui H; Mu Y; Yu L; Xi YG; Matthiesen R; Su X; Sun W
    Fam Cancer; 2016 Apr; 15(2):317-24. PubMed ID: 26463235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
    Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
    Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
    Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.
    Chen HS; Lu AQ; Yang PY; Liang J; Wei Y; Shang YW; Li Q
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6621-6628. PubMed ID: 31378904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
    Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
    Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma.
    Katakowski M; Zheng X; Jiang F; Rogers T; Szalad A; Chopp M
    Cancer Invest; 2010 Dec; 28(10):1024-30. PubMed ID: 20874002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and Invasion.
    Xia Z; Liu F; Zhang J; Liu L
    PLoS One; 2015; 10(7):e0132399. PubMed ID: 26134825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades.
    Ichimura K; Schmidt EE; Miyakawa A; Goike HM; Collins VP
    Genes Chromosomes Cancer; 1998 May; 22(1):9-15. PubMed ID: 9591629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.
    Yan W; Li R; Liu Y; Yang P; Wang Z; Zhang C; Bao Z; Zhang W; You Y; Jiang T
    Oncotarget; 2014 Dec; 5(24):12908-15. PubMed ID: 25415048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global microRNA profiling identified miR-10b-5p as a regulator of neurofibromatosis 1 (NF1)-glioma migration.
    Nix JS; Yuan M; Imada EL; Ames H; Marchionni L; Gutmann DH; Rodriguez FJ
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):96-107. PubMed ID: 32603552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.
    Malzkorn B; Wolter M; Liesenberg F; Grzendowski M; Stühler K; Meyer HE; Reifenberger G
    Brain Pathol; 2010 May; 20(3):539-50. PubMed ID: 19775293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
    Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
    Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.